Trial Profile
Pilot study on efficacy of a simplification strategy from DRV/r 600/100 mg BID to DRV/r 800/100mg QD + OBT in HIV-positive patients HAART-experienced with virological response.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2014
Price :
$35
*
At a glance
- Drugs Darunavir (Primary) ; Ritonavir
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms DRV-exp
- 30 Jun 2014 New trial record